Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study.
Journal Information
Full Title: BMC Cancer
Abbreviation: BMC Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateDue to the retrospective nature of this study, the ethical approval and informed consent requirements from each patient have been waived according to the regulations of the Tianjin Medical University Cancer Institute and Hospital Ethics Committee. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests Competing interests The authors declare that they have no competing interests"
"Funding This work was supported by grants from the National Natural Science Foundation of China (Nos. 82103677) and Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009 A)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025